Your total testosterone came back at 320 ng/dL and your doctor says it's "low-normal." You're exhausted, your libido is gone, and you can't shake the brain fog — but you're told the number doesn't justify treatment.
That single total testosterone reading tells less than half the story.
A comprehensive testosterone assessment measures not just total testosterone, but the bioavailable and free forms that actually reach your tissues and do the work. It accounts for sex hormone-binding globulin (SHBG) and albumin — the binding proteins that trap most of your testosterone in an inactive state.1
This matters because up to 30% of men with initially low testosterone levels see normal results on repeat testing, and many men with "normal" total testosterone have genuinely deficient bioavailable levels due to elevated SHBG.2 Without measuring the full picture, you risk years of untreated symptoms — or unnecessary treatment that carries real risks.
This guide walks you through what a comprehensive testosterone assessment actually includes, why the individual components matter, how to interpret your results, and what steps to take based on your complete hormonal profile. Whether you're experiencing symptoms, already on therapy, or trying to make sense of conflicting test results, understanding the full assessment is the foundation of informed decision-making.
Normal adult male range: 270-1,070 ng/dL total testosterone (lab-dependent)
Diagnosis threshold: Two tests below 300 ng/dL or low bioavailable testosterone
Test-retest variability: 30% of single low readings normalize on repeat2
Bioavailable fraction: Approximately 40-50% of total testosterone
SHBG binding: Traps 60% of testosterone in inactive form
Related topics: Primary vs secondary hypogonadism, TRT monitoring protocols, fertility preservation options, managing elevated hematocrit
Next step: Schedule two morning (7-11am) blood draws 2-4 weeks apart if you're experiencing symptoms. Request comprehensive panel including total testosterone (LC-MS/MS method), SHBG, albumin for bioavailable calculation, LH, FSH, estradiol, prolactin, and thyroid function tests.
What a Comprehensive Assessment Actually Measures
A complete testosterone evaluation goes far beyond a single total testosterone number. It measures multiple hormone fractions and binding proteins to reveal how much testosterone is actually available to your tissues.
Total Testosterone: The Starting Point
Total testosterone represents everything in your bloodstream — both bound and unbound. Normal adult male ranges typically fall between 270-1,070 ng/dL, though these ranges vary by laboratory and measurement method.3
The measurement seems straightforward, but the method matters enormously. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard, offering precision especially at lower concentrations where older immunoassays often fail.4
That precision becomes critical when your levels hover near diagnostic thresholds. A reading of 280 ng/dL on an immunoassay might actually be 320 ng/dL on LC-MS/MS — the difference between a Hypogonadism diagnosis and being told you're fine.
Free Testosterone: What's Actually Available
Only about 2% of your testosterone circulates in a free, unbound state. This tiny fraction is immediately available to enter cells and activate androgen receptors — it's the testosterone that actually does the work.1
Direct free testosterone assays exist, but most guidelines recommend against them due to accuracy issues. Instead, free testosterone is calculated from your total testosterone, SHBG, and albumin using validated formulas.
Bioavailable Testosterone: The Functional Reserve
Bioavailable testosterone includes both free testosterone and testosterone loosely bound to albumin. This represents the testosterone that can dissociate and become active in tissues — roughly 40-50% of your total.
Calculated bioavailable testosterone (cBAT) often reveals deficiencies that total testosterone misses entirely. A 55-year-old man might have total testosterone of 450 ng/dL — seemingly adequate — but elevated SHBG from aging could drop his bioavailable testosterone well into the deficient range.
SHBG: The Binding Protein That Changes Everything
SHBG binds about 60% of circulating testosterone with high affinity, rendering it biologically inactive.5 SHBG levels rise with age, obesity, Insulin Resistance, and certain medications — especially if you're on TRT gel formulations.
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is a highly precise laboratory technique that separates and identifies testosterone molecules, offering superior accuracy especially at lower hormone concentrations where older immunoassays often fail.
Why Single Tests Miss the Diagnosis
Testosterone levels fluctuate wildly — not just across months, but within hours. Morning levels run 20-30% higher than afternoon readings. Stress, illness, poor sleep, and even intense exercise can temporarily suppress production.
Clinical guidelines universally recommend two morning blood draws, collected 7-11am and separated by 2-4 weeks.6 Only when both tests show deficiency — total testosterone below 300 ng/dL or low calculated bioavailable testosterone — does a diagnosis become reliable.
Research shows 30% of men with one low reading test normal on repeat.2 That's nearly one in three men who would receive a misdiagnosis based on a single test.
The SHBG Variable
SHBG changes the entire calculation. When SHBG rises — common in aging, liver disease, hyperthyroidism, and with certain medications — it traps more testosterone in an inactive form.
Your total testosterone might read 400 ng/dL, but if SHBG is elevated, your free and bioavailable fractions could be deficient. Without measuring SHBG, this discrepancy remains invisible.
Albumin's Supporting Role
Albumin binds about 38% of testosterone, but with much weaker affinity than SHBG. This albumin-bound testosterone can dissociate and become available — it's part of your bioavailable pool. Albumin levels typically stay stable unless you have liver disease, kidney disease, or severe malnutrition.
Sex Hormone-Binding Globulin (SHBG) is a protein that binds approximately 60% of circulating testosterone with high affinity, rendering it biologically inactive and unavailable to tissues. SHBG levels increase with age, obesity, insulin resistance, and certain medications.
Additional Hormones That Complete the Picture
A comprehensive assessment extends beyond testosterone itself to measure the hormones that regulate production and respond to changes in testosterone levels.
Luteinizing Hormone and Follicle-Stimulating Hormone
LH signals your testes to produce testosterone. FSH drives sperm production. Together, they distinguish primary hypogonadism (testicular failure, marked by high LH/FSH and Low Testosterone) from Secondary Hypogonadism (pituitary or hypothalamic failure, marked by low or inappropriately normal LH/FSH with low testosterone).7
This distinction determines treatment approach. Primary hypogonadism typically requires testosterone replacement. Secondary hypogonadism might respond to medications that stimulate your own production, preserving fertility.
Estradiol: The Overlooked Player
Testosterone converts to estradiol through aromatization — especially in fat tissue. On TRT, some men over-convert and develop elevated estradiol, causing water retention, mood instability, and gynecomastia.
Baseline estradiol measurement establishes your natural set point. Monitoring during therapy catches excessive aromatization early, before symptoms emerge.
Prolactin and Thyroid Function
Elevated prolactin suppresses testosterone production and causes symptoms that mimic hypogonadism — fatigue, low libido, erectile dysfunction. A prolactinoma (pituitary tumor) can be the root cause, making this a critical screening test.
Thyroid hormones (TSH, free T3, free T4) directly influence metabolism, energy, and mood. Hypothyroidism produces symptoms nearly identical to low testosterone. Testing both avoids the mistake of treating testosterone deficiency when the real problem is thyroid dysfunction.
Aromatization is the enzymatic conversion of testosterone to estradiol, occurring primarily in fat tissue. On testosterone replacement therapy, excessive aromatization can cause water retention, mood instability, and gynecomastia.
Interpreting Your Results
Numbers without context mean nothing. A total testosterone of 350 ng/dL tells one story for a 25-year-old bodybuilder and a completely different story for a 60-year-old man with diabetes.
Understanding Reference Ranges
Laboratory reference ranges typically span 264-916 ng/dL for adult men, but these are statistical constructs — the middle 95% of tested populations. They don't define "optimal" or "symptomatic."3
A reading in the low-normal range (300-400 ng/dL) might be perfectly adequate for one man and profoundly deficient for another. Age matters. A 70-year-old man with a total testosterone of 320 ng/dL might feel fine. A 30-year-old man with the same number often experiences significant symptoms.
When Bioavailable Testosterone Reveals the Truth
Calculated bioavailable testosterone becomes the deciding factor when total testosterone sits in the gray zone. Guidelines increasingly emphasize cBAT as superior for confirming hypogonadism, especially in older men or those with altered SHBG.1
The bottom line: If your total testosterone is borderline but your bioavailable testosterone is clearly deficient, you have biochemical hypogonadism regardless of where total testosterone falls on the reference range.
Red Flags That Demand Further Investigation
Certain patterns in your hormone panel signal specific problems requiring immediate follow-up:
- Elevated prolactin. Levels above 20-25 ng/mL warrant pituitary imaging to rule out prolactinoma.
- Very low LH and FSH with low testosterone. Points to secondary hypogonadism from pituitary or hypothalamic dysfunction.
- High LH and FSH with low testosterone. Indicates primary testicular failure.
- Elevated estradiol without TRT. Suggests excessive aromatization, often linked to obesity or liver dysfunction.
- Abnormal thyroid values. Hypothyroidism must be addressed before attributing symptoms to low testosterone.
How Assessment Changes During TRT
Once you start therapy, monitoring requirements shift. You're no longer diagnosing deficiency — you're ensuring treatment achieves target levels without adverse effects.
Initial Monitoring Phase
The first 3-6 months on TRT require closer tracking. Most protocols recommend checking total testosterone (and sometimes free testosterone) at 3 months, then 6 months, to confirm you've reached therapeutic range without overshooting.
Timing matters depending on delivery method. For testosterone enanthate or cypionate injections, test at trough (right before your next injection) or mid-cycle (3-4 days after injection for weekly protocols).5 For gels, test 2-8 hours after application once steady-state is reached.
Long-Term Monitoring
After levels stabilize, annual testing usually suffices. These checks should include:
- Total testosterone. Confirms you remain in therapeutic range (typically 450-750 ng/dL, though targets vary).
- Hematocrit. Elevated red blood cell counts (polycythemia) are the most common TRT side effect, increasing cardiovascular risk.
- PSA and digital rectal exam. Monitors prostate health, though TRT doesn't cause cancer.
- Estradiol (if symptomatic). Tracks aromatization if you develop gynecomastia, water retention, or mood issues.
When to Reassess Comprehensively
Return to comprehensive hormone panels if symptoms return despite seemingly adequate testosterone levels. Elevated SHBG can rise during therapy (especially with gels), trapping more of your supplemented testosterone and recreating the deficiency despite higher total levels.
Polycythemia is an abnormal elevation in red blood cell count, the most common side effect of testosterone replacement therapy that increases cardiovascular risk and requires monitoring through hematocrit testing.
Key Takeaways for Your Assessment
Never diagnose testosterone deficiency from a single test. Guidelines require two morning blood draws 2-4 weeks apart, both showing total testosterone below 300 ng/dL or low calculated bioavailable testosterone.6
Total testosterone alone misses critical information. SHBG and albumin binding determine how much testosterone actually reaches your tissues. A "normal" total testosterone reading can coexist with deficient bioavailable testosterone if SHBG is elevated.
The full hormone panel matters. LH and FSH distinguish testicular failure from pituitary dysfunction. Prolactin screening catches treatable tumors. Thyroid testing prevents misattributing hypothyroid symptoms to low testosterone. Estradiol baseline guides TRT management.
Timing affects results dramatically. Test between 7-11am when testosterone peaks naturally. Avoid testing during illness, after poor sleep, or following intense training — all suppress testosterone temporarily.
Method matters for accuracy. LC-MS/MS provides superior precision compared to older immunoassays, especially at lower testosterone levels where diagnostic decisions hinge on small numerical differences.4
Bioavailable testosterone calculation trumps direct free testosterone measurement. Most clinical guidelines recommend calculated bioavailable testosterone (cBAT) over unreliable direct free testosterone assays when total testosterone is borderline.
Research Context and Clinical Evolution
The shift toward comprehensive assessment reflects decades of clinical learning. Early testosterone replacement relied exclusively on total testosterone measurements, leading to both overtreatment of men with adequate bioavailable levels and undertreatment of men with binding protein abnormalities.
The Endocrine Society's 2018 clinical practice guidelines formalized the two-test requirement and elevated calculated bioavailable testosterone as a diagnostic tool.4 These recommendations built on meta-analyses showing substantial test-retest variability in testosterone levels — the 30% normalization rate on repeat testing that now drives the two-draw standard.
Provincial and national guidelines worldwide have converged on similar protocols. BC Guidelines specify calculated bioavailable testosterone over redundant free testosterone calculations, explicitly recommending against single tests.5 The Australian Endocrine Society and European Association of Urology echo these approaches with minor regional variations.
The LC-MS/MS Revolution
Liquid chromatography-tandem mass spectrometry transformed testosterone measurement accuracy. Older immunoassays showed significant cross-reactivity with other steroids and poor precision at concentrations below 300 ng/dL — exactly where diagnostic accuracy matters most.
LC-MS/MS separates testosterone molecules by mass and charge, eliminating cross-reactivity and achieving coefficient of variation below 5% even at low concentrations. Major laboratories have transitioned to LC-MS/MS for testosterone testing over the past decade, though some smaller facilities still rely on immunoassays.
The Bioavailable Testosterone Validation Studies
Calculated bioavailable testosterone gained credibility through validation against equilibrium dialysis — the reference method for measuring free testosterone that's too technically demanding for routine clinical use. Studies demonstrated that calculated values using total testosterone, SHBG, and albumin correlated strongly with dialysis measurements (r > 0.95) while being far more practical.1
This mathematical approach accounts for the known binding constants between testosterone and its carrier proteins, producing reliable estimates of both free and bioavailable fractions without the expense and technical complexity of direct measurement.
Population Statistics and Age-Related Decline
Large epidemiological studies quantified the natural testosterone decline with aging. The Massachusetts Male Aging Study found total testosterone drops approximately 1-2% per year after age 30, while free testosterone declines even faster due to rising SHBG.2
By age 70, many men have total testosterone levels 30-50% below their peak values in the 20s. This creates diagnostic complexity — is a 320 ng/dL reading in a 65-year-old man pathological or age-appropriate?
The answer lies in symptoms and bioavailable testosterone. Guidelines increasingly recognize that age-based reference ranges may be needed, though consensus on specific thresholds remains elusive.
Turning Assessment Into Action
Your testosterone results in hand, you face the next question: what now? The path forward depends on what your comprehensive panel revealed.
If Both Tests Show Deficiency
Two morning blood draws showing total testosterone below 300 ng/dL, or clearly low calculated bioavailable testosterone, combined with symptoms warrant a treatment discussion. Before starting TRT, your doctor should:
- Rule out reversible causes. Obesity, poor sleep, uncontrolled diabetes, medication side effects, and excessive alcohol all suppress testosterone production.
- Confirm you're not trying to conceive. TRT suppresses sperm production, often causing infertility within months.
- Screen for contraindications. Uncontrolled heart failure, severe sleep apnea, elevated hematocrit, active prostate cancer, and untreated breast cancer are all relative or absolute contraindications.
- Discuss formulation options. Injections, gels, patches, and nasal formulations each have distinct pharmacokinetics, convenience factors, and side effect profiles.
If One Test Is Low, One Is Normal
Inconsistent results mean repeating the assessment in another 2-4 weeks. If the third test is normal, you likely don't have persistent hypogonadism. If it's low, you have two abnormal results and can proceed with treatment discussions.
During this waiting period, address modifiable factors. Lose weight if obese. Prioritize sleep. Reduce alcohol. Optimize diabetes or thyroid control. These interventions sometimes normalize testosterone without medication.
If Total Is Low-Normal But Bioavailable Is Deficient
This pattern — common in older men with elevated SHBG — represents biochemical hypogonadism despite total testosterone in the low-normal range. Treatment decisions hinge on symptom severity and how much SHBG elevation is driving the discrepancy.
Weight loss and insulin sensitivity improvement can lower SHBG. If symptoms are mild to moderate, a 3-6 month trial of lifestyle intervention makes sense before committing to lifelong TRT.
Questions to Ask Your Doctor
Armed with your comprehensive results, bring these questions to your appointment:
- What's my bioavailable testosterone? Many labs report only total testosterone unless specifically ordered otherwise.
- Were my tests done with LC-MS/MS or immunoassay? If immunoassay and borderline, request LC-MS/MS confirmation.
- What's causing my low levels? Primary testicular failure, secondary pituitary/hypothalamic dysfunction, or reversible factors like obesity?
- Should we address thyroid, prolactin, or other abnormalities first? Treating secondary causes might normalize testosterone without TRT.
- What happens if we don't treat? Understand risks of ongoing deficiency versus treatment risks.
- How will we monitor during treatment? Clarify testing frequency, target levels, and parameters to track.
When to Consider a Second Opinion
Seek another evaluation if your doctor dismisses symptoms despite documented biochemical deficiency, refuses to measure bioavailable testosterone when total is borderline, bases treatment decisions on a single test, or suggests TRT without checking LH/FSH/prolactin/thyroid first.
Endocrinologists and urologists specializing in men's health typically provide more nuanced assessment than general practitioners, though many GPs manage testosterone effectively using guideline-based protocols.